Smart Vesicle Therapeutics: Engineering Precision at the Nanoscale.

Area of Science:

• Nanomedicine
• Biotechnology
• Therapeutics

Background:

• Smart vesicles, including liposomes, niosomes, polymersomes, and extracellular vesicles (EVs), are key platforms in nanomedicine.
• They offer biocompatible and adaptable systems for drug delivery and theranostic applications.

Purpose of the Study:

• To review recent advances in the design and engineering of smart vesicles.
• To highlight their capabilities in integrating therapeutic and diagnostic functions.
• To discuss challenges and emerging solutions for clinical translation.

Main Methods:

• Tailoring vesicle properties (size, composition, surface chemistry).
• Engineering stimuli-responsive and hybrid bio-inspired systems.
• Integrating diagnostic functions for theranostic applications.

Main Results:

• Improved pharmacokinetics, reduced immunogenicity, and controlled drug release.
• Spatiotemporal regulation of therapeutic action via stimuli-responsive designs.
• Enhanced precision medicine through real-time monitoring and adaptive treatment control.

Conclusions:

• Smart vesicles represent a convergence of nanotechnology, biotechnology, and clinical science.
• They are driving the development of safer, more effective, and personalized precision therapies.
• Overcoming challenges in production and standardization is crucial for clinical translation.